Jamjoom Pharmaceuticals Factory Company (4015.SR)
SAR 157.4
(-0.51%)
SAR 157.4
(-0.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 296.02 Million | 229.2 Million | 228.69 Million | 261.93 Million | 203.57 Million | 112.71 Million |
| Net Income | 315.79 Million | 186.31 Million | 188.08 Million | 231.74 Million | 156.93 Million | 150.83 Million |
| Depreciation & Amortization | 26.62 Million | 24.72 Million | 24.35 Million | 42.22 Million | 42.55 Million | 42.46 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -49.32 Million | -32.74 Million | 26.44 Million | -19.87 Million | -20.84 Million | -90.57 Million |
| Other non-cash items | 2.92 Million | 50.9 Million | -10.18 Million | 7.84 Million | 127.17 Million | 181.82 Million |
| Investing Cash Flow | -77.44 Million | -54.47 Million | -143.26 Million | -178.49 Million | -70.02 Million | -84.39 Million |
| Investments in PPE | -45.77 Million | -87.65 Million | -126.8 Million | -163.61 Million | -70.99 Million | -46.95 Million |
| Acquisitions | -31.71 Million | 148.36 Thousand | 138.87 Thousand | 143.2 Thousand | 971.81 Thousand | 174.71 Thousand |
| Investment purchases | -31.71 Million | -33.17 Million | -19.07 Million | - | - | -37.61 Million |
| Sales/Maturities of investments | 31.71 Million | 33.02 Million | 18.93 Million | - | - | - |
| Other Investing Activities | 52.29 Thousand | 33.17 Million | -16.45 Million | -15.02 Million | -1.62 Million | -37.58 Million |
| Financing Cash Flow | -70.34 Million | -149 Million | -208.34 Million | -28.46 Million | -100 Million | -110 Million |
| Debt repayment | -347.26 Thousand | -347.25 Thousand | -95.01 Million | -16 Million | -14 Million | -10 Million |
| Dividends payments | -70 Million | -148.78 Million | -113.33 Million | -90.66 Million | -86 Million | -100 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -347.26 Thousand | -224.99 Thousand | - | 78.2 Million | - | - |
| Accounts receivables | 18.03 Million | 12.19 Million | 46.74 Million | 7.92 Million | -57.03 Million | -44.15 Million |
| Accounts payables | 44.53 Million | -18.88 Million | -3.59 Million | 21.22 Million | 8.1 Million | 5.95 Million |
| Inventory | -114.42 Million | -7.51 Million | -16.71 Million | -48.79 Million | 31.79 Million | -48.7 Million |
| Other working capital | 2.54 Million | -18.52 Million | -13.54 Million | -231.05 Thousand | -3.7 Million | -3.66 Million |
| Cash at beginning of period | 141.18 Million | 112.62 Million | 235.54 Million | 180.57 Million | 147.01 Million | 228.7 Million |
| Cash at end of period | 284.27 Million | 141.18 Million | 112.62 Million | 235.54 Million | 180.57 Million | 147.01 Million |
| Capital Expenditure | -45.77 Million | -87.65 Million | -126.8 Million | -163.61 Million | -70.99 Million | -46.95 Million |
| Effect of forex changes on cash | -5.14 Million | 2.83 Million | -458.75 Thousand | - | - | - |
| Net cash flow / Change in cash | 143.09 Million | 28.55 Million | -122.91 Million | 54.97 Million | 33.55 Million | -81.68 Million |
| Free Cash Flow | 250.25 Million | 141.55 Million | 101.88 Million | 98.32 Million | 132.57 Million | 65.75 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 106.95 Million | 112.73 Million | 315.79 Million | 47.1 Million | 83.85 Million | 92.98 Million |
| Depreciation & Amortization | 9.77 Million | 7.57 Million | 26.62 Million | 7.2 Million | 6.72 Million | 6.41 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -38.08 Million | -176.2 Million | -49.32 Million | 154.3 Million | -60.57 Million | -8.83 Million |
| Other non-cash items | 34.44 Million | 173.92 Thousand | 2.92 Million | -8.43 Million | 10.76 Million | -5.26 Million |
| Investing Cash Flow | -20.3 Million | -21.32 Million | -77.44 Million | -8.75 Million | -47.99 Million | -8.14 Million |
| Investments in PPE | -14.7 Million | -21.68 Million | -45.77 Million | -8.79 Million | -17.89 Million | -6.52 Million |
| Acquisitions | -6072.00 | 360.51 Thousand | -31.71 Million | 39.7 Thousand | - | 5217.00 |
| Investment purchases | -5.59 Million | - | -31.71 Million | - | -30.09 Million | -1.62 Million |
| Sales/Maturities of investments | - | - | 31.71 Million | - | - | -5217.00 |
| Other Investing Activities | -5.56 Million | 258.62 Thousand | 52.29 Thousand | 30.65 Thousand | -30.68 Million | 5217.00 |
| Financing Cash Flow | -105.03 Million | -234.01 Thousand | -70.34 Million | -84.73 Thousand | -70 Million | -30.02 Thousand |
| Debt repayment | -32.66 Thousand | -234.01 Thousand | -347.26 Thousand | -84.73 Thousand | -1103.00 | -30.02 Thousand |
| Dividends payments | -105 Million | - | -70 Million | - | -70 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -32.66 Thousand | - | - | -84.73 Thousand | -1103.00 | -30.02 Thousand |
| Accounts receivables | -82.17 Million | -220.82 Million | 18.03 Million | 244.97 Million | -51.5 Million | -34.41 Million |
| Accounts payables | 67.49 Million | 38.71 Million | 44.53 Million | -46.47 Million | 22.88 Million | 48.99 Million |
| Inventory | -9.28 Million | 6.46 Million | -114.42 Million | -46.23 Million | -31.21 Million | -31.28 Million |
| Other working capital | -14.12 Million | -1.08 Million | 2.54 Million | 2.04 Million | -737.88 Thousand | 7.86 Million |
| Cash at beginning of period | 210.47 Million | 284.27 Million | 141.18 Million | 93.19 Million | 170.26 Million | 93.8 Million |
| Cash at end of period | 156.25 Million | 210.47 Million | 284.27 Million | 284.27 Million | 93.19 Million | 170.26 Million |
| Capital Expenditure | -14.7 Million | -21.68 Million | -45.77 Million | -8.79 Million | -17.89 Million | -6.52 Million |
| Effect of forex changes on cash | 1.54 Million | -5.34 Million | -5.14 Million | -258.03 Thousand | 139.08 Thousand | -661.95 Thousand |
| Net cash flow / Change in cash | -54.22 Million | -73.79 Million | 143.09 Million | 191.08 Million | -77.07 Million | 76.46 Million |
| Free Cash Flow | 54.86 Million | -68.58 Million | 250.25 Million | 191.38 Million | 22.87 Million | 78.77 Million |
0HBQ
0QZF
NXL
TPRKY
7538
QPM